Namiki Shunichi, Saito Seiichi, Tochigi Tatsuo, Numata Isao, Ioritani Naomasa, Arai Yoichi
Department of Urology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Int J Urol. 2007 Oct;14(10):924-9. doi: 10.1111/j.1442-2042.2007.01746.x.
To investigate: (i) the level of psychological distress; and (ii) the relationships between the level of psychological distress and general or disease-specific HRQOL of Japanese men with localized prostate cancer following surgery or radiotherapy.
The study was a retrospective cross-sectional survey of 253 men with localized prostate cancer treated with radical prostatectomy and 87 with external beam radiotherapy were collected. The measures used four questionnaires including: (i) the Medical Outcomes Study 36-Item Health Survey; (ii) The University of California, Los Angeles Prostate Cancer Index; (iii) International Prostate Symptom Score; and (iv) Hospital Anxiety and Depression Scale (HADS).
Mean anxiety and depression scores were 4.0 and 4.7, respectively (standard deviation, 3.3 and 3.7). On the anxiety section of HADS, 291 patients (85%) scored 7 points or less; and on the depression scale, 183 (54%) patients scored 4 points or less. Those 'cases' (HADS total, >10) with psychological distress scored lower in all domains of the general and disease related health-related quality of life (HRQOL) than the 'non-cases' (HADS total, <or=10) except for sexual domains. Logistic regression modeling suggested that the men who tended to experience moderate to high distress suffered from worse urinary and bowel symptoms.
Most patients who underwent radical prostatectomy or external beam radiotherapy for localized prostate cancer experienced low levels of psychological distress after treatment. However, men who were experiencing urinary and bowel symptoms tended to suffer from moderate to higher distress compared with men reporting no or fewer such symptoms.
调查:(i)心理困扰水平;(ii)日本局限性前列腺癌男性患者在手术后或放疗后心理困扰水平与一般或疾病特异性健康相关生活质量(HRQOL)之间的关系。
本研究是一项回顾性横断面调查,收集了253例行根治性前列腺切除术的局限性前列腺癌男性患者以及87例行外照射放疗的患者的数据。所使用的测量工具包括四份问卷:(i)医学结局研究简明健康调查;(ii)加利福尼亚大学洛杉矶分校前列腺癌指数;(iii)国际前列腺症状评分;以及(iv)医院焦虑抑郁量表(HADS)。
焦虑和抑郁平均得分分别为4.0和4.7(标准差分别为3.3和3.7)。在HADS焦虑量表部分,291名患者(85%)得分7分及以下;在抑郁量表部分,183名患者(54%)得分4分及以下。心理困扰“病例”(HADS总分>10)在一般和疾病相关的健康相关生活质量(HRQOL)的所有领域得分均低于“非病例”(HADS总分≤10),性领域除外。逻辑回归模型表明,倾向于经历中度至高度困扰的男性存在更严重的泌尿和肠道症状。
大多数接受局限性前列腺癌根治性前列腺切除术或外照射放疗的患者在治疗后心理困扰水平较低。然而,与未报告或报告此类症状较少的男性相比,有泌尿和肠道症状的男性往往会经历中度至更高水平的困扰。